STOCK TITAN

Celanese Corp (CE) SVP adds 2,153 shares in open-market stock purchase

(Neutral)
(Positive)
Form Type
4

Rhea-AI Filing Summary

Celanese Corp SVP Mark Christopher Murray purchased additional company shares. On 2026-08-11, he bought 2,153 shares of Common Stock in a purchase in open market or private transaction at $45.5199 per share. Following this transaction, he directly holds 30,432 shares of Celanese Common Stock.

Positive

  • None.

Negative

  • None.
Insider Murray Mark Christopher
Role SVP - Acetyls
Bought 2,153 shs ($98K)
Type Security Shares Price Value
Purchase Common Stock 2,153 $45.5199 $98K
Holdings After Transaction: Common Stock — 30,432 shares (Direct)
Shares purchased 2,153 shares Common Stock purchased on 2026-08-11
Purchase price $45.5199 per share Price for Common Stock purchase on 2026-08-11
Shares owned after transaction 30,432 shares Direct holdings of Mark Christopher Murray following the purchase
Buy transactions in filing 1 transaction Total reported buy transactions in this Form 4
Net buy/sell shares 2,153 shares Net effect of reported transactions is a net-buy of 2,153 shares
purchase in open market or private transaction regulatory
"Transaction code P described as purchase in open market or private transaction"
Common Stock financial
"Security title for the reported transaction is Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
direct ownership financial
"Ownership type for the position after the transaction is direct"
Form 4 regulatory
"Insider transaction reported on Form 4 for Celanese Corp"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Celanese (CE) report for Mark Christopher Murray?

Celanese reported that SVP Mark Christopher Murray purchased 2,153 shares of Common Stock on 2026-08-11. The transaction was a purchase in open market or private transaction at $45.5199 per share.

How many Celanese (CE) shares does Mark Christopher Murray own after this trade?

After the reported transaction, SVP Mark Christopher Murray directly holds 30,432 shares of Celanese Common Stock. This total reflects his position following the 2,153-share purchase on 2026-08-11.

What price did the Celanese (CE) insider pay for the purchased shares?

The Celanese insider purchase was executed at $45.5199 per share for 2,153 Common Stock shares. The filing describes the transaction as a purchase in open market or private transaction on 2026-08-11.

Was the Celanese (CE) insider trade made under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirming plan use, and no footnote indicates a Rule 10b5-1 trading plan. The transaction is described simply as a purchase in open market or private transaction.

Is the Celanese (CE) insider transaction a buy or a sell?

The reported transaction is a buy. SVP Mark Christopher Murray purchased 2,153 shares of Celanese Common Stock, coded as a P – purchase in open market or private transaction, increasing his direct holdings to 30,432 shares.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Murray Mark Christopher

(Last)(First)(Middle)
222 W. LAS COLINAS BLVD
STE 900N

(Street)
IRVING TEXAS 75039

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP - Acetyls
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/11/2026P2,153A$45.519930,432D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Christine Dryden, Attorney-in-Fact for Mark Christopher Murray08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)